T1	Participants 36 63	first episode schizophrenia
T2	Participants 117 130	schizophrenia
T3	Participants 338 463	patients with first episode schizophrenia; that is, before the effects of chronic illness, institutionalization, or treatment
T4	Participants 492 552	307 schizophrenia subjects in their first episode of illness
T5	Participants 668 804	The psychopathology, cognitive functioning, early treatment history, and duration of untreated psychosis of these subjects were assessed
T6	Participants 870 1043	Approximately two-thirds of the subjects were receiving antipsychotic treatment at the time of assessment; however, the duration of treatment was limited to 12 weeks or less
